Global Fund Blitz Aims to Offset Shortfall 20/09/2022 Kerry Cullinan The Global Fund goes into its pledging conference on Wednesday substantially short of its $18 billion minimum target to fight HIV/AIDS, tuberculosis and malaria over the next five years. Hosted by US President Joe Biden on the sidelines of the United Nations General Assembly (UNGA), the seventh replenishment conference is the culmination of a months-long […] Continue reading -> Global Fund Replenishment Gains Steam 13/09/2022 Kerry Cullinan As the push for adequate funds to address HIV, tuberculosis and malaria reaches its climax with next week’s replenishment meeting of the Global Fund, the fund’s latest report reveals it has saved 50 million lives between 2002 and 2021. The Global Fund raises money in three-year cycles and seeks $18 billion for its seventh replenishment, […] Continue reading -> Unitaid Invests in New TB Tests, as South Africa Study Reports Importance of Better Screening 06/09/2022 Kerry Cullinan Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Global Fund Strategy to Reduce Deaths from AIDS, TB, and Malaria Still Leaves TB Behind 13/05/2022 Raisa Santos With a target to raise at least $18 billion to save 20 million lives, and reduce mortality from HIV/AIDS, TB, and malaria by 64%, the Global Fund to Fight AIDS, Tuberculosis, and Malaria is gearing up to implement its ambitious new strategy to defeat these longstanding pandemics by 2030. However, even though TB kills more […] Continue reading -> Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> Ukraine’s ‘Model’ TB Programme Destroyed by War, as Global TB Response Faces ‘Disastrous’ Funds Shortfall 22/03/2022 Kerry Cullinan & Elaine Ruth Fletcher Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Fund Replenishment Gains Steam 13/09/2022 Kerry Cullinan As the push for adequate funds to address HIV, tuberculosis and malaria reaches its climax with next week’s replenishment meeting of the Global Fund, the fund’s latest report reveals it has saved 50 million lives between 2002 and 2021. The Global Fund raises money in three-year cycles and seeks $18 billion for its seventh replenishment, […] Continue reading -> Unitaid Invests in New TB Tests, as South Africa Study Reports Importance of Better Screening 06/09/2022 Kerry Cullinan Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Global Fund Strategy to Reduce Deaths from AIDS, TB, and Malaria Still Leaves TB Behind 13/05/2022 Raisa Santos With a target to raise at least $18 billion to save 20 million lives, and reduce mortality from HIV/AIDS, TB, and malaria by 64%, the Global Fund to Fight AIDS, Tuberculosis, and Malaria is gearing up to implement its ambitious new strategy to defeat these longstanding pandemics by 2030. However, even though TB kills more […] Continue reading -> Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> Ukraine’s ‘Model’ TB Programme Destroyed by War, as Global TB Response Faces ‘Disastrous’ Funds Shortfall 22/03/2022 Kerry Cullinan & Elaine Ruth Fletcher Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unitaid Invests in New TB Tests, as South Africa Study Reports Importance of Better Screening 06/09/2022 Kerry Cullinan Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Global Fund Strategy to Reduce Deaths from AIDS, TB, and Malaria Still Leaves TB Behind 13/05/2022 Raisa Santos With a target to raise at least $18 billion to save 20 million lives, and reduce mortality from HIV/AIDS, TB, and malaria by 64%, the Global Fund to Fight AIDS, Tuberculosis, and Malaria is gearing up to implement its ambitious new strategy to defeat these longstanding pandemics by 2030. However, even though TB kills more […] Continue reading -> Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> Ukraine’s ‘Model’ TB Programme Destroyed by War, as Global TB Response Faces ‘Disastrous’ Funds Shortfall 22/03/2022 Kerry Cullinan & Elaine Ruth Fletcher Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Global Fund Strategy to Reduce Deaths from AIDS, TB, and Malaria Still Leaves TB Behind 13/05/2022 Raisa Santos With a target to raise at least $18 billion to save 20 million lives, and reduce mortality from HIV/AIDS, TB, and malaria by 64%, the Global Fund to Fight AIDS, Tuberculosis, and Malaria is gearing up to implement its ambitious new strategy to defeat these longstanding pandemics by 2030. However, even though TB kills more […] Continue reading -> Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> Ukraine’s ‘Model’ TB Programme Destroyed by War, as Global TB Response Faces ‘Disastrous’ Funds Shortfall 22/03/2022 Kerry Cullinan & Elaine Ruth Fletcher Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Global Fund Strategy to Reduce Deaths from AIDS, TB, and Malaria Still Leaves TB Behind 13/05/2022 Raisa Santos With a target to raise at least $18 billion to save 20 million lives, and reduce mortality from HIV/AIDS, TB, and malaria by 64%, the Global Fund to Fight AIDS, Tuberculosis, and Malaria is gearing up to implement its ambitious new strategy to defeat these longstanding pandemics by 2030. However, even though TB kills more […] Continue reading -> Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> Ukraine’s ‘Model’ TB Programme Destroyed by War, as Global TB Response Faces ‘Disastrous’ Funds Shortfall 22/03/2022 Kerry Cullinan & Elaine Ruth Fletcher Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Global Fund Strategy to Reduce Deaths from AIDS, TB, and Malaria Still Leaves TB Behind 13/05/2022 Raisa Santos With a target to raise at least $18 billion to save 20 million lives, and reduce mortality from HIV/AIDS, TB, and malaria by 64%, the Global Fund to Fight AIDS, Tuberculosis, and Malaria is gearing up to implement its ambitious new strategy to defeat these longstanding pandemics by 2030. However, even though TB kills more […] Continue reading -> Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> Ukraine’s ‘Model’ TB Programme Destroyed by War, as Global TB Response Faces ‘Disastrous’ Funds Shortfall 22/03/2022 Kerry Cullinan & Elaine Ruth Fletcher Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> Global Fund Strategy to Reduce Deaths from AIDS, TB, and Malaria Still Leaves TB Behind 13/05/2022 Raisa Santos With a target to raise at least $18 billion to save 20 million lives, and reduce mortality from HIV/AIDS, TB, and malaria by 64%, the Global Fund to Fight AIDS, Tuberculosis, and Malaria is gearing up to implement its ambitious new strategy to defeat these longstanding pandemics by 2030. However, even though TB kills more […] Continue reading -> Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> Ukraine’s ‘Model’ TB Programme Destroyed by War, as Global TB Response Faces ‘Disastrous’ Funds Shortfall 22/03/2022 Kerry Cullinan & Elaine Ruth Fletcher Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Fund Strategy to Reduce Deaths from AIDS, TB, and Malaria Still Leaves TB Behind 13/05/2022 Raisa Santos With a target to raise at least $18 billion to save 20 million lives, and reduce mortality from HIV/AIDS, TB, and malaria by 64%, the Global Fund to Fight AIDS, Tuberculosis, and Malaria is gearing up to implement its ambitious new strategy to defeat these longstanding pandemics by 2030. However, even though TB kills more […] Continue reading -> Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> Ukraine’s ‘Model’ TB Programme Destroyed by War, as Global TB Response Faces ‘Disastrous’ Funds Shortfall 22/03/2022 Kerry Cullinan & Elaine Ruth Fletcher Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Looking Beyond New TB Vaccines to Shorter Courses of Treatment 24/03/2022 Paul Adepoju The world remains fixated on getting new TB vaccines. But expanding the circle of progress on shorter TB regimes, and more early detection, may be more important to overcoming setbacks of the COVID pandemic, says one expert on World TB Day. IBADAN, Nigeria – The Government Chest Hospital in the city’s Jericho neighborhood is regarded […] Continue reading -> Ukraine’s ‘Model’ TB Programme Destroyed by War, as Global TB Response Faces ‘Disastrous’ Funds Shortfall 22/03/2022 Kerry Cullinan & Elaine Ruth Fletcher Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Ukraine’s ‘Model’ TB Programme Destroyed by War, as Global TB Response Faces ‘Disastrous’ Funds Shortfall 22/03/2022 Kerry Cullinan & Elaine Ruth Fletcher Speaking in her car from an undisclosed location somewhere in war-torn Ukraine, Yana Teerleva, head of TB in the country’s Ministry of Health, lamented the destruction that she is witnessing every day in hospitals and clinics – including the shelling of three huge dispensaries where the country had stockpiled sufficient TB medications for the remainder […] Continue reading -> Posts navigation Older postsNewer posts